Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

Clinical trial NCT00425373 · COMPLETED

Trial details

NCT number: NCT00425373
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2006-11-01
Primary completion: 2008-03-01
Enrollment: 1474

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.